VectorBuilder Redefines Plasmid Standards with miniVec
Conventional plasmids as a pharmaceutical material are not only suboptimal in safety and function, but exceedingly costly to produce, prohibitively
Conventional plasmids as a pharmaceutical material are not only suboptimal in safety and function, but exceedingly costly to produce, prohibitively
New study presents a human-relevant stress model for assessing potential therapeutics
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
These products strengthen poultry immunity, improve productivity, and support sustainable farming practices~
IMCD engaged with manufacturers, formulators, and brand leaders, offering valuable insights into evolving consumer trends
Datroway becomes the first and only therapy to show overall survival benefit versus chemotherapy in this difficult-to-treat patient population
Medico Remedies receives order worth US$ 1,781,000
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
This collaboration aims to combine Molcure’s cutting-edge AI technology with Boehringer Ingelheim’s extensive expertise in drug discovery
Subscribe To Our Newsletter & Stay Updated